A Study of the Long-term Safety and Tolerability of an Investigational Drug in People With Schizophrenia.
Status:
Recruiting
Trial end date:
2022-03-04
Target enrollment:
Participant gender:
Summary
A clinical study to evaluate the long-term safety and tolerability of an investigational drug
in people with schizophrenia.
This study is accepting male and female participants between 18 years old -65 years old who
have been diagnosed with schizophrenia. This study will be conducted in approximately 50
study centers worldwide. The study will last approximately 57 weeks.